Duopharma Biotech Berhad (KLSE:DPHARMA)

Duopharma Biotech Berhad Revenue

Duopharma Biotech Berhad had revenue of 247.88M MYR in the quarter ending March 31, 2026, a decrease of -5.66%. This brings the company's revenue in the last twelve months to 916.83M, up 3.78% year-over-year. In the year 2025, Duopharma Biotech Berhad had annual revenue of 931.69M with 14.50% growth.

• Revenue (ttm): 916.83M
• Revenue Growth: +3.78%
• P/S Ratio: 1.28
• Revenue / Employee: 468.49K
• Employees: 1,957
• Market Cap: 1.17B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	931.69M	118.00M	14.50%
Dec 31, 2024	813.70M	108.97M	15.46%
Dec 31, 2023	704.73M	8.01M	1.15%
Dec 31, 2022	696.72M	57.54M	9.00%
Dec 31, 2021	639.18M	69.27M	12.16%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 3, 2026

Data Sources Report a data error